An algorithm to predict risk of Type 2 diabetes in Turkish adults: Contribution of C-reactive protein

Journal of Endocrinological Investigation

Volumn 34, Issue 8, 2011, Pages 580-586

  Onat, A ^a   Can, G ^a   Yuksel H ^a   Ayhan, E ^b   Dogan, Y ^c   Hergenc G ^d  

^a ISTANBUL UNIVERSITY   (Turkey)

^b DR SIYAMI ERSEK THORACIC AND CARDIOVASCULAR SURGERY TRAINING AND RESEARCH HOSPITAL   (Turkey)

^c Bakirkoy Education Training Hospital   (Turkey)

^d YILDIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

C reactive protein; Incidence; Metabolic syndrome; Risk score; Screening; Type 2 diabetes

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE;

ADULT; ALGORITHM; ARTICLE; FAMILY HISTORY; FEMALE; HUMAN; IMMOBILIZATION; INCOME; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; TURKEY (REPUBLIC); WAIST CIRCUMFERENCE;

ADULT; ALGORITHMS; C-REACTIVE PROTEIN; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK FACTORS; ROC CURVE; TURKEY;

EID: 84855457483     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.3275/7323     Document Type: Article

References (31)

1. Griffin SI, Little PS, Hales CN, Kinmonth AL, Wareham NJ. Diabetes risk score: towards earlier detection of type 2 diabetes in general practice. Diabetes Metab Res Rev 2000, 16: 164-71. (Pubitemid 30410271)
2. Stern MP, Williams K, Haffner SM. Identification of persons at high risk for type 2 diabetes: do we need the oral glucose tolerance test? Ann Intern Med 2002, 136: 575-81. (Pubitemid 34407041)
3. Lindström J, Tuomilehto J. The diabetes risk score: a practical score to predict risk of type two diabetes. Diabetes Care 2003, 26: 725-31. (Pubitemid 36929335)
4. McNeely MJ, Boyko EJ, Leonetti DL, Kahn SE, Fujimoto WY. Comparison of a clinical model, the oral glucose tolerance test, and fasting glucose for prediction of type 2 diabetes in Japanese Americans. Diabetes Care 2003, 26: 758-63. (Pubitemid 36929340)
5. Wilson PW, Meigs JB, Sullivan L, Fox CS, Nathan DM, D'Agostino RB Sr. Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. Arch Intern Med 2007, 167: 1068-74. (Pubitemid 46835795)
6. Hippisley-Cox J, Coupland C, Robson J, Sheikh A, Brindle P. Predicting risk of type 2 diabetes in England and Wales: prospective derivation and validation of QDScore. BMJ 2009, 338: b880.
7. Onat A, Uyarel H, Hergenç G, Karabulut A, Albayrak S, Can G. Determinants and definition of abdominal obesity as related to risk of diabetes, metabolic syndrome and coronary disease in Turkish men: a prospective cohort study. Atherosclerosis 2007, 191: 182-90. (Pubitemid 46237629)
8. Onat A, Ceyhan K, Basar Ö, Erer B, Toprak S, Sansoy V. Metabolic syndrome, major impact on coronary risk in a population with low cholesterol levels - a prospective and cross-sectional evaluation. Atherosclerosis 2002, 165: 285-92. (Pubitemid 35339372)
9. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001, 285: 2486-97.
10. Onat A, Can G, Hergenç G. Serum C-reactive protein is an independent risk factor predicting cardiometabolic risk. Metabolism 2008, 57: 207-14.
11. Onat A, Hergenç G, Keles I, Dogan Y, Türkmen S, Sansoy V. Sex difference in development of diabetes and cardiovascular disease on the way from obesity and metabolic syndrome: prospective study of a cohort with normal glucose metabolism. Metabolism 2005, 54: 800-8. (Pubitemid 40731508)
12. Han TS, Sattar N, Williams K, Gonzales-Villalpando C, Lean ME, Haffner SM. Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study. Diabetes Care 2002, 25: 2016-21. (Pubitemid 41071061)
13. Hanley AJ, Williams K, Gonzalez C, et al; San Antonio Heart Study; Mexico City Diabetes Study; Insulin Resistance Atherosclerosis Study. Prediction of type 2 diabetes using simple measures of insulin resistance: combined results from the San Antonio Heart Study, the Mexico City Diabetes Study, and the Insulin Resistance Atherosclerosis Study. Diabetes 2003, 52: 463-9. (Pubitemid 36173204)
14. Chien K, Cai T, Hsu H, et al. A prediction model for type 2 diabetes risk among Chinese people. Diabetologia 2009, 52: 443-50.
15. Abdul-Ghani MA, Williams K, DeFronzo RA, Stern M. What is the best predictor of future type 2 diabetes? Diabetes Care 2007, 30: 1544-8. (Pubitemid 46871168)
16. Onat A. Risk factors and cardiovascular disease in Turkey. Atherosclerosis 2001, 156: 1-10. (Pubitemid 32429589)
17. Genuth S, Alberti KG, Bennett P, et al Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003, 26: 3160-7.
18. Rahman M, Simmons R, Harding A, Wareham N, Griffin S. A simple risk score identifies individuals at high risk of developing type 2 diabetes: a prospective cohort study. Fam Pract 2008, 25: 191-6. (Pubitemid 351965938)
19. Glümer C, Carstensen B, Sandbaek A, Lauritzen T, Jørgensen T, Borch-Johnsen K; inter99 study. A Danish diabetes risk score for targeted screening: the Iner99 study. Diabetes Care 2004, 27: 727-33. (Pubitemid 38280541)
20. Schmidt MI, Duncan BB, Bang H, et al Atherosclerosis Risk in Communities Investigators. Identifying individuals at high risk for diabetes: the Atherosclerosis Risk in Communities study. Diabetes Care 2005, 28: 2013-8. (Pubitemid 41060977)
21. Schulze MB, Hoffmann K, Boeing H, et al. An accurate risk score based on anthropometric, dietary, and lifestyle factors to predict the development of type 2 diabetes. Diabetes Care 2007, 30: 510-5. (Pubitemid 46354326)
22. Lindström J, Louheranta A, Mannelin M, et al Finnish Diabetes Prevention Study Group. The Finnish Diabetes Prevention Study (DPS): lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care 2003, 26: 3230-6. (Pubitemid 37466880)
23. Hu G, Jousilahti P, Tuomilehto J, Antikainen R, Sundvall J, Salomaa V. Association of serum C-reactive protein level with sex-specific type 2 diabetes risk: a prospective Finnish study. J Clin Endocrinol Metab 2009, 94: 2099-105.
24. Wannamethee SG, Papacosta O, Whincup PH, et al. Assessing prediction of diabetes in older adults using different adiposity measures: a 7 year prospective study in 6,923 older men and women. Diabetologia 2010, 53: 890-8.
25. Fabbri L, Rabe K. From COPD to chronic systemic inflammatory syndrome? Lancet 2007, 370: 797-9. (Pubitemid 47320803)
26. Onat A, Can G, Ayhan E, Kaya Z, Hergenç G. Impaired protection against diabetes and coronary disease by high-density lipoproteins in Turks. Metabolism 2009, 58: 1393-9.
27. Onat A, Hergenç G, Bulur S, Ugur M, Küçükdurmaz Z, Can G. The paradox of high apolipoprotein A-I levels independently predicting incident type-2 diabetes among Turks. Int J Cardiol 2010, 142: 72-9.
28. Pencina MJ, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008, 27: 157-72. (Pubitemid 351193639)
29. Rimm EB, Manson JE, Stampfer MJ, et al. Cigarette smoking and the risk of diabetes in women. Am J Publ Health 1993, 83: 211-4. (Pubitemid 23046478)
30. Onat A, Özhan H, Esen AM, et al. Prospective epidemiologic evidence of a "protective" effect of smoking on metabolic syndrome and diabetes among Turkish women - without associated overall health benefit. Atherosclerosis 2007, 193: 380-9.
31. Feskens EJ, van Dam RM. Dietary fat and the etiology of type 2 diabetes: an epidemiological perspective. Nutr Metab Cardiovasc Dis 1999, 9: 87-95. (Pubitemid 129634404)